

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 6.73343318 |
| 2 | hyperosmotic salinity response (GO:0042538) | 6.19039724 |
| 3 | positive regulation of prostaglandin secretion (GO:0032308) | 6.10446351 |
| 4 | regulation of RIG-I signaling pathway (GO:0039535) | 5.96286470 |
| 5 | sequestering of actin monomers (GO:0042989) | 5.56921680 |
| 6 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 5.40827481 |
| 7 | regulation of female receptivity (GO:0045924) | 5.12290221 |
| 8 | sleep (GO:0030431) | 5.03359479 |
| 9 | mannosylation (GO:0097502) | 4.98997441 |
| 10 | regulation of prostaglandin secretion (GO:0032306) | 4.96517039 |
| 11 | regulation of uterine smooth muscle contraction (GO:0070472) | 4.95220336 |
| 12 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.93599011 |
| 13 | GPI anchor biosynthetic process (GO:0006506) | 4.91326827 |
| 14 | aggressive behavior (GO:0002118) | 4.83344500 |
| 15 | preassembly of GPI anchor in ER membrane (GO:0016254) | 4.75864079 |
| 16 | glial cell proliferation (GO:0014009) | 4.56983581 |
| 17 | GPI anchor metabolic process (GO:0006505) | 4.56198270 |
| 18 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.55786019 |
| 19 | female mating behavior (GO:0060180) | 4.38224211 |
| 20 | behavioral response to ethanol (GO:0048149) | 4.25701531 |
| 21 | righting reflex (GO:0060013) | 4.23351286 |
| 22 | regulation of protein polyubiquitination (GO:1902914) | 4.22375715 |
| 23 | negative regulation of heart rate (GO:0010459) | 4.13396849 |
| 24 | limb bud formation (GO:0060174) | 4.12580894 |
| 25 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 4.06724568 |
| 26 | regulation of penile erection (GO:0060405) | 4.02540440 |
| 27 | gonadal mesoderm development (GO:0007506) | 4.00633575 |
| 28 | maternal behavior (GO:0042711) | 3.99495932 |
| 29 | drinking behavior (GO:0042756) | 3.85625763 |
| 30 | positive regulation of icosanoid secretion (GO:0032305) | 3.84945524 |
| 31 | maturation of SSU-rRNA (GO:0030490) | 3.83711177 |
| 32 | ATP synthesis coupled proton transport (GO:0015986) | 3.77383478 |
| 33 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.77383478 |
| 34 | positive regulation of TOR signaling (GO:0032008) | 3.72195886 |
| 35 | positive regulation of catecholamine secretion (GO:0033605) | 3.68822870 |
| 36 | somite development (GO:0061053) | 3.66891329 |
| 37 | adult feeding behavior (GO:0008343) | 3.63211412 |
| 38 | viral transcription (GO:0019083) | 3.62993605 |
| 39 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.62588494 |
| 40 | cornea development in camera-type eye (GO:0061303) | 3.62186113 |
| 41 | nucleobase catabolic process (GO:0046113) | 3.59606799 |
| 42 | tachykinin receptor signaling pathway (GO:0007217) | 3.55365214 |
| 43 | forebrain neuron differentiation (GO:0021879) | 3.53862342 |
| 44 | positive regulation of fatty acid transport (GO:2000193) | 3.52661963 |
| 45 | parental behavior (GO:0060746) | 3.48634390 |
| 46 | translational termination (GO:0006415) | 3.46217748 |
| 47 | neural tube formation (GO:0001841) | 3.45672212 |
| 48 | positive regulation of digestive system process (GO:0060456) | 3.37804061 |
| 49 | neurotransmitter catabolic process (GO:0042135) | 3.34345090 |
| 50 | negative regulation of digestive system process (GO:0060457) | 3.20117566 |
| 51 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.18486163 |
| 52 | protein localization to vacuole (GO:0072665) | 3.13812323 |
| 53 | protein localization to lysosome (GO:0061462) | 3.13812323 |
| 54 | C-terminal protein amino acid modification (GO:0018410) | 3.12132694 |
| 55 | viral genome replication (GO:0019079) | 3.11796679 |
| 56 | ribosomal small subunit assembly (GO:0000028) | 3.09749251 |
| 57 | cardiac right ventricle morphogenesis (GO:0003215) | 3.08619607 |
| 58 | translational elongation (GO:0006414) | 3.07537483 |
| 59 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.07263167 |
| 60 | activated T cell proliferation (GO:0050798) | 3.03052648 |
| 61 | C-terminal protein lipidation (GO:0006501) | 3.01547115 |
| 62 | glycolipid biosynthetic process (GO:0009247) | 3.01480922 |
| 63 | N-acetylglucosamine metabolic process (GO:0006044) | 2.98035682 |
| 64 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.97511845 |
| 65 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.95899204 |
| 66 | protein localization to synapse (GO:0035418) | 2.93898674 |
| 67 | type B pancreatic cell proliferation (GO:0044342) | 2.92567908 |
| 68 | regulation of urine volume (GO:0035809) | 2.91414131 |
| 69 | cotranslational protein targeting to membrane (GO:0006613) | 2.91337517 |
| 70 | positive regulation of heart rate (GO:0010460) | 2.89278337 |
| 71 | response to dietary excess (GO:0002021) | 2.88084661 |
| 72 | cullin deneddylation (GO:0010388) | 2.87153284 |
| 73 | electron transport chain (GO:0022900) | 2.86871966 |
| 74 | chaperone-mediated protein transport (GO:0072321) | 2.84291786 |
| 75 | spinal cord development (GO:0021510) | 2.83919470 |
| 76 | regulation of dopamine metabolic process (GO:0042053) | 2.83770763 |
| 77 | regulation of catecholamine metabolic process (GO:0042069) | 2.83770763 |
| 78 | protein targeting to ER (GO:0045047) | 2.83620117 |
| 79 | grooming behavior (GO:0007625) | 2.82472060 |
| 80 | regulation of icosanoid secretion (GO:0032303) | 2.82284637 |
| 81 | negative regulation of necroptotic process (GO:0060546) | 2.80513046 |
| 82 | negative regulation of glial cell proliferation (GO:0060253) | 2.79046405 |
| 83 | respiratory electron transport chain (GO:0022904) | 2.77103043 |
| 84 | hair cycle (GO:0042633) | 2.73124044 |
| 85 | molting cycle (GO:0042303) | 2.73124044 |
| 86 | lysine catabolic process (GO:0006554) | 2.73024554 |
| 87 | lysine metabolic process (GO:0006553) | 2.73024554 |
| 88 | protein localization to cilium (GO:0061512) | 2.67560884 |
| 89 | cellular protein complex disassembly (GO:0043624) | 2.67212561 |
| 90 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.66835816 |
| 91 | protein localization to endoplasmic reticulum (GO:0070972) | 2.65066166 |
| 92 | positive regulation of meiosis (GO:0045836) | 2.65026646 |
| 93 | positive regulation of smooth muscle contraction (GO:0045987) | 2.64442946 |
| 94 | protein complex disassembly (GO:0043241) | 2.63404580 |
| 95 | response to prostaglandin E (GO:0034695) | 2.61065549 |
| 96 | meiotic chromosome segregation (GO:0045132) | 2.60272535 |
| 97 | behavioral response to nicotine (GO:0035095) | 2.59671473 |
| 98 | NIK/NF-kappaB signaling (GO:0038061) | 2.57960569 |
| 99 | otic vesicle formation (GO:0030916) | 2.57721378 |
| 100 | behavioral defense response (GO:0002209) | 2.50767415 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.12086476 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.74660156 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.38563763 |
| 4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.08474683 |
| 5 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.03745194 |
| 6 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.01037423 |
| 7 | RNF2_27304074_Chip-Seq_NSC_Mouse | 2.90802365 |
| 8 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.63475271 |
| 9 | VDR_22108803_ChIP-Seq_LS180_Human | 2.44289503 |
| 10 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.42090295 |
| 11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.38564688 |
| 12 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.37706392 |
| 13 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.34626267 |
| 14 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.23371384 |
| 15 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.21942073 |
| 16 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.21113262 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.12734882 |
| 18 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 2.12056972 |
| 19 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 2.08331433 |
| 20 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.00702924 |
| 21 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.99986054 |
| 22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.95001710 |
| 23 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.89998173 |
| 24 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.85825721 |
| 25 | EWS_26573619_Chip-Seq_HEK293_Human | 1.85073895 |
| 26 | P300_19829295_ChIP-Seq_ESCs_Human | 1.79890167 |
| 27 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.79441627 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.74946525 |
| 29 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.72323706 |
| 30 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.72228972 |
| 31 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.65795767 |
| 32 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.64877121 |
| 33 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.64877121 |
| 34 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.63662980 |
| 35 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.59494639 |
| 36 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.59494639 |
| 37 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.58984351 |
| 38 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.58616384 |
| 39 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.57642915 |
| 40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.57408080 |
| 41 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.56483624 |
| 42 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.55781806 |
| 43 | FUS_26573619_Chip-Seq_HEK293_Human | 1.54882961 |
| 44 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.53175034 |
| 45 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.53166314 |
| 46 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.52792696 |
| 47 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.51914852 |
| 48 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.50698718 |
| 49 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.50299633 |
| 50 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.49701147 |
| 51 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.49644073 |
| 52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.47308486 |
| 53 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.45299724 |
| 54 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.44618148 |
| 55 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.44547487 |
| 56 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.43089144 |
| 57 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.43030773 |
| 58 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.38672626 |
| 59 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.36991153 |
| 60 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.36652842 |
| 61 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.30679574 |
| 62 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.30495221 |
| 63 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.29063228 |
| 64 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.28300921 |
| 65 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.25804672 |
| 66 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.22718396 |
| 67 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.22021914 |
| 68 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.21629873 |
| 69 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.21420897 |
| 70 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.19885343 |
| 71 | NCOR_22424771_ChIP-Seq_293T_Human | 1.19610241 |
| 72 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.18486906 |
| 73 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.15595523 |
| 74 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.15375851 |
| 75 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.15375851 |
| 76 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.14018748 |
| 77 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.09388947 |
| 78 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.08671471 |
| 79 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.07429047 |
| 80 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.07298795 |
| 81 | AR_25329375_ChIP-Seq_VCAP_Human | 1.04414007 |
| 82 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.03657559 |
| 83 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.03513822 |
| 84 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03142463 |
| 85 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.02390398 |
| 86 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.00575989 |
| 87 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.98789985 |
| 88 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98066303 |
| 89 | AR_20517297_ChIP-Seq_VCAP_Human | 0.97872721 |
| 90 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.96919529 |
| 91 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.96592254 |
| 92 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.95849779 |
| 93 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.95729856 |
| 94 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.95729856 |
| 95 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.95709903 |
| 96 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.94686310 |
| 97 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94513999 |
| 98 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.93773639 |
| 99 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.92546529 |
| 100 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.92245833 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 4.99925727 |
| 2 | MP0006276_abnormal_autonomic_nervous | 4.54927410 |
| 3 | MP0006292_abnormal_olfactory_placode | 4.47297226 |
| 4 | MP0000566_synostosis | 3.26362472 |
| 5 | MP0005645_abnormal_hypothalamus_physiol | 3.23064942 |
| 6 | MP0003880_abnormal_central_pattern | 3.21042689 |
| 7 | MP0001502_abnormal_circadian_rhythm | 2.75445424 |
| 8 | MP0003122_maternal_imprinting | 2.57467889 |
| 9 | MP0000778_abnormal_nervous_system | 2.46357431 |
| 10 | MP0000372_irregular_coat_pigmentation | 2.39533496 |
| 11 | MP0003011_delayed_dark_adaptation | 2.22401409 |
| 12 | MP0006072_abnormal_retinal_apoptosis | 2.15239623 |
| 13 | MP0002876_abnormal_thyroid_physiology | 2.14233539 |
| 14 | MP0003283_abnormal_digestive_organ | 2.11481252 |
| 15 | MP0001529_abnormal_vocalization | 2.06213827 |
| 16 | MP0004142_abnormal_muscle_tone | 1.98702520 |
| 17 | MP0000631_abnormal_neuroendocrine_gland | 1.98657814 |
| 18 | MP0003136_yellow_coat_color | 1.88459832 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 1.76303627 |
| 20 | MP0002751_abnormal_autonomic_nervous | 1.68223440 |
| 21 | MP0001905_abnormal_dopamine_level | 1.63454700 |
| 22 | MP0004859_abnormal_synaptic_plasticity | 1.61197416 |
| 23 | MP0004270_analgesia | 1.52622526 |
| 24 | MP0003315_abnormal_perineum_morphology | 1.51880214 |
| 25 | MP0005084_abnormal_gallbladder_morpholo | 1.49904332 |
| 26 | MP0002102_abnormal_ear_morphology | 1.46559801 |
| 27 | MP0003718_maternal_effect | 1.45922569 |
| 28 | MP0003806_abnormal_nucleotide_metabolis | 1.42818674 |
| 29 | MP0008877_abnormal_DNA_methylation | 1.41959577 |
| 30 | MP0003121_genomic_imprinting | 1.41818202 |
| 31 | MP0004885_abnormal_endolymph | 1.41488456 |
| 32 | MP0002009_preneoplasia | 1.39895808 |
| 33 | MP0004742_abnormal_vestibular_system | 1.36517933 |
| 34 | MP0002064_seizures | 1.36427917 |
| 35 | MP0005253_abnormal_eye_physiology | 1.34856550 |
| 36 | MP0001440_abnormal_grooming_behavior | 1.34762854 |
| 37 | MP0004147_increased_porphyrin_level | 1.34473023 |
| 38 | MP0002234_abnormal_pharynx_morphology | 1.32780227 |
| 39 | MP0002557_abnormal_social/conspecific_i | 1.31907686 |
| 40 | MP0009745_abnormal_behavioral_response | 1.26170343 |
| 41 | MP0003119_abnormal_digestive_system | 1.24992554 |
| 42 | MP0000955_abnormal_spinal_cord | 1.22013706 |
| 43 | MP0005257_abnormal_intraocular_pressure | 1.21310935 |
| 44 | MP0002653_abnormal_ependyma_morphology | 1.19512517 |
| 45 | MP0002184_abnormal_innervation | 1.19462309 |
| 46 | MP0003635_abnormal_synaptic_transmissio | 1.16546345 |
| 47 | MP0002938_white_spotting | 1.16281715 |
| 48 | MP0000049_abnormal_middle_ear | 1.12382854 |
| 49 | MP0005386_behavior/neurological_phenoty | 1.11192267 |
| 50 | MP0004924_abnormal_behavior | 1.11192267 |
| 51 | MP0009046_muscle_twitch | 1.07408234 |
| 52 | MP0000534_abnormal_ureter_morphology | 1.07324332 |
| 53 | MP0005551_abnormal_eye_electrophysiolog | 1.04342562 |
| 54 | MP0005195_abnormal_posterior_eye | 1.02679574 |
| 55 | MP0003878_abnormal_ear_physiology | 1.02605642 |
| 56 | MP0005377_hearing/vestibular/ear_phenot | 1.02605642 |
| 57 | MP0002572_abnormal_emotion/affect_behav | 1.01420477 |
| 58 | MP0000647_abnormal_sebaceous_gland | 1.01146700 |
| 59 | MP0002736_abnormal_nociception_after | 0.98494466 |
| 60 | MP0004811_abnormal_neuron_physiology | 0.98353971 |
| 61 | MP0009053_abnormal_anal_canal | 0.97538216 |
| 62 | MP0008872_abnormal_physiological_respon | 0.96569633 |
| 63 | MP0002882_abnormal_neuron_morphology | 0.96222922 |
| 64 | MP0002909_abnormal_adrenal_gland | 0.94747471 |
| 65 | MP0002063_abnormal_learning/memory/cond | 0.93824165 |
| 66 | MP0005646_abnormal_pituitary_gland | 0.92983131 |
| 67 | MP0002272_abnormal_nervous_system | 0.92354413 |
| 68 | MP0002752_abnormal_somatic_nervous | 0.92341227 |
| 69 | MP0002067_abnormal_sensory_capabilities | 0.90675435 |
| 70 | MP0003938_abnormal_ear_development | 0.90399291 |
| 71 | MP0000026_abnormal_inner_ear | 0.88713289 |
| 72 | MP0001664_abnormal_digestion | 0.88113529 |
| 73 | MP0002160_abnormal_reproductive_system | 0.87563177 |
| 74 | MP0001501_abnormal_sleep_pattern | 0.87116294 |
| 75 | MP0000653_abnormal_sex_gland | 0.85283915 |
| 76 | MP0002210_abnormal_sex_determination | 0.83666609 |
| 77 | MP0001929_abnormal_gametogenesis | 0.83225036 |
| 78 | MP0000516_abnormal_urinary_system | 0.81877287 |
| 79 | MP0005367_renal/urinary_system_phenotyp | 0.81877287 |
| 80 | MP0000537_abnormal_urethra_morphology | 0.80489567 |
| 81 | MP0003638_abnormal_response/metabolism_ | 0.78649294 |
| 82 | MP0004019_abnormal_vitamin_homeostasis | 0.78365717 |
| 83 | MP0008875_abnormal_xenobiotic_pharmacok | 0.78277375 |
| 84 | MP0005389_reproductive_system_phenotype | 0.77840871 |
| 85 | MP0003329_amyloid_beta_deposits | 0.74887201 |
| 86 | MP0001340_abnormal_eyelid_morphology | 0.74247650 |
| 87 | MP0003698_abnormal_male_reproductive | 0.74178939 |
| 88 | MP0010386_abnormal_urinary_bladder | 0.72271630 |
| 89 | MP0001970_abnormal_pain_threshold | 0.72051000 |
| 90 | MP0005391_vision/eye_phenotype | 0.71996220 |
| 91 | MP0001177_atelectasis | 0.71585981 |
| 92 | MP0001145_abnormal_male_reproductive | 0.69866336 |
| 93 | MP0002697_abnormal_eye_size | 0.67692418 |
| 94 | MP0000465_gastrointestinal_hemorrhage | 0.66884577 |
| 95 | MP0003866_abnormal_defecation | 0.66751791 |
| 96 | MP0003724_increased_susceptibility_to | 0.65158264 |
| 97 | MP0010030_abnormal_orbit_morphology | 0.65099919 |
| 98 | MP0001881_abnormal_mammary_gland | 0.64067065 |
| 99 | MP0000639_abnormal_adrenal_gland | 0.63456920 |
| 100 | MP0005423_abnormal_somatic_nervous | 0.63161152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cerebellar dysplasia (HP:0007033) | 4.05964172 |
| 2 | Increased hepatocellular lipid droplets (HP:0006565) | 3.87980511 |
| 3 | Abnormality of the labia minora (HP:0012880) | 3.61968514 |
| 4 | Type II lissencephaly (HP:0007260) | 3.54446170 |
| 5 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.50814471 |
| 6 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.50814471 |
| 7 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.36188112 |
| 8 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.36188112 |
| 9 | Renal Fanconi syndrome (HP:0001994) | 3.22768695 |
| 10 | Acute necrotizing encephalopathy (HP:0006965) | 3.22657398 |
| 11 | Limb dystonia (HP:0002451) | 3.19290913 |
| 12 | Abnormal number of erythroid precursors (HP:0012131) | 3.14575786 |
| 13 | Mitochondrial inheritance (HP:0001427) | 3.14266054 |
| 14 | Lipid accumulation in hepatocytes (HP:0006561) | 3.10968027 |
| 15 | Limb-girdle muscle atrophy (HP:0003797) | 3.08895023 |
| 16 | Exertional dyspnea (HP:0002875) | 2.97287814 |
| 17 | Hypoplasia of the pons (HP:0012110) | 2.95134221 |
| 18 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.94029042 |
| 19 | Leukodystrophy (HP:0002415) | 2.92614166 |
| 20 | Progressive macrocephaly (HP:0004481) | 2.91559672 |
| 21 | Acute encephalopathy (HP:0006846) | 2.91018397 |
| 22 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.90697578 |
| 23 | Shoulder girdle muscle weakness (HP:0003547) | 2.88782408 |
| 24 | Hyperglycinemia (HP:0002154) | 2.87914945 |
| 25 | Calf muscle hypertrophy (HP:0008981) | 2.86619712 |
| 26 | Abnormality of the pons (HP:0007361) | 2.81021632 |
| 27 | Megalencephaly (HP:0001355) | 2.77945230 |
| 28 | Congenital stationary night blindness (HP:0007642) | 2.75467242 |
| 29 | Abnormality of midbrain morphology (HP:0002418) | 2.70889497 |
| 30 | Molar tooth sign on MRI (HP:0002419) | 2.70889497 |
| 31 | Pachygyria (HP:0001302) | 2.69077603 |
| 32 | Increased intramyocellular lipid droplets (HP:0012240) | 2.68799415 |
| 33 | Pelvic girdle muscle weakness (HP:0003749) | 2.59515011 |
| 34 | Global brain atrophy (HP:0002283) | 2.56131379 |
| 35 | Pancreatic fibrosis (HP:0100732) | 2.54878646 |
| 36 | Generalized aminoaciduria (HP:0002909) | 2.54385499 |
| 37 | True hermaphroditism (HP:0010459) | 2.53555180 |
| 38 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.52656053 |
| 39 | Large eyes (HP:0001090) | 2.48268062 |
| 40 | Increased CSF lactate (HP:0002490) | 2.48117255 |
| 41 | Myokymia (HP:0002411) | 2.46320918 |
| 42 | Septo-optic dysplasia (HP:0100842) | 2.40671047 |
| 43 | Metaphyseal dysplasia (HP:0100255) | 2.36778240 |
| 44 | Hypoplastic pelvis (HP:0008839) | 2.34935585 |
| 45 | Hypoventilation (HP:0002791) | 2.34266146 |
| 46 | 3-Methylglutaconic aciduria (HP:0003535) | 2.32284773 |
| 47 | Lissencephaly (HP:0001339) | 2.31453015 |
| 48 | Poor suck (HP:0002033) | 2.31053791 |
| 49 | Hepatocellular necrosis (HP:0001404) | 2.30691667 |
| 50 | Abnormality of the anterior horn cell (HP:0006802) | 2.27320836 |
| 51 | Degeneration of anterior horn cells (HP:0002398) | 2.27320836 |
| 52 | Hyperphosphaturia (HP:0003109) | 2.26362527 |
| 53 | Nephronophthisis (HP:0000090) | 2.21758638 |
| 54 | Amniotic constriction ring (HP:0009775) | 2.12335162 |
| 55 | Abnormality of placental membranes (HP:0011409) | 2.12335162 |
| 56 | Reticulocytopenia (HP:0001896) | 2.10652812 |
| 57 | Growth hormone excess (HP:0000845) | 2.09111904 |
| 58 | Optic nerve hypoplasia (HP:0000609) | 2.08960021 |
| 59 | Synostosis involving the elbow (HP:0003938) | 2.08864494 |
| 60 | Humeroradial synostosis (HP:0003041) | 2.08864494 |
| 61 | Patellar aplasia (HP:0006443) | 2.08805603 |
| 62 | Pancreatic cysts (HP:0001737) | 2.08299539 |
| 63 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.01876033 |
| 64 | Abnormality of urine glucose concentration (HP:0011016) | 2.01573608 |
| 65 | Glycosuria (HP:0003076) | 2.01573608 |
| 66 | Hepatic necrosis (HP:0002605) | 2.01423597 |
| 67 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.00555928 |
| 68 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.00351954 |
| 69 | Agitation (HP:0000713) | 2.00058113 |
| 70 | Maternal diabetes (HP:0009800) | 1.99610321 |
| 71 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.99400565 |
| 72 | Broad-based gait (HP:0002136) | 1.95869975 |
| 73 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.95866683 |
| 74 | Optic disc pallor (HP:0000543) | 1.95365197 |
| 75 | Abnormality of renal resorption (HP:0011038) | 1.94576325 |
| 76 | Hypercortisolism (HP:0001578) | 1.92524694 |
| 77 | Chronic hepatic failure (HP:0100626) | 1.92430529 |
| 78 | Abnormal sex determination (HP:0012244) | 1.90569130 |
| 79 | Sex reversal (HP:0012245) | 1.90569130 |
| 80 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.90232942 |
| 81 | Increased muscle lipid content (HP:0009058) | 1.90174386 |
| 82 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.89035924 |
| 83 | Hypothermia (HP:0002045) | 1.89018545 |
| 84 | Hemiplegia (HP:0002301) | 1.88803660 |
| 85 | Abnormality of dental color (HP:0011073) | 1.87894701 |
| 86 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 1.84821396 |
| 87 | Stenosis of the external auditory canal (HP:0000402) | 1.84670374 |
| 88 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.84606992 |
| 89 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.84218870 |
| 90 | Abnormality of the renal medulla (HP:0100957) | 1.83419000 |
| 91 | Respiratory difficulties (HP:0002880) | 1.80857416 |
| 92 | Spastic paraparesis (HP:0002313) | 1.80762051 |
| 93 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.79949592 |
| 94 | Polyphagia (HP:0002591) | 1.78234859 |
| 95 | Exocrine pancreatic insufficiency (HP:0001738) | 1.77273232 |
| 96 | Hypoplasia of the brainstem (HP:0002365) | 1.77029895 |
| 97 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.77029895 |
| 98 | Absent septum pellucidum (HP:0001331) | 1.75323803 |
| 99 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.74825989 |
| 100 | Parakeratosis (HP:0001036) | 1.74525623 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 5.21806322 |
| 2 | MAP4K2 | 3.81060464 |
| 3 | EPHA3 | 3.34719110 |
| 4 | CDK19 | 2.60387707 |
| 5 | CASK | 2.59821139 |
| 6 | TNIK | 2.59596178 |
| 7 | MARK1 | 2.57582104 |
| 8 | MAP3K12 | 2.50780173 |
| 9 | DYRK2 | 2.37339693 |
| 10 | NUAK1 | 2.36113493 |
| 11 | TLK1 | 2.17465114 |
| 12 | ERBB3 | 2.14316098 |
| 13 | TRIM28 | 2.11385923 |
| 14 | ARAF | 1.93974253 |
| 15 | UHMK1 | 1.90113044 |
| 16 | CSNK1G2 | 1.89729529 |
| 17 | LATS2 | 1.88911244 |
| 18 | DYRK1B | 1.66795295 |
| 19 | WNK3 | 1.59853598 |
| 20 | PINK1 | 1.58096940 |
| 21 | FLT3 | 1.54172818 |
| 22 | ADRBK2 | 1.49768532 |
| 23 | TXK | 1.45671400 |
| 24 | ZAK | 1.45437419 |
| 25 | VRK1 | 1.43297937 |
| 26 | TYRO3 | 1.41992745 |
| 27 | BCR | 1.37391154 |
| 28 | CSNK1G3 | 1.35324063 |
| 29 | BCKDK | 1.32347144 |
| 30 | PLK2 | 1.30014499 |
| 31 | BMPR2 | 1.27383044 |
| 32 | MAP2K7 | 1.25585607 |
| 33 | STK16 | 1.18342034 |
| 34 | FES | 1.12502039 |
| 35 | MOS | 1.11465620 |
| 36 | EPHB2 | 1.11011384 |
| 37 | NTRK1 | 1.07130072 |
| 38 | MAPK13 | 1.06738632 |
| 39 | MAP3K13 | 1.05248360 |
| 40 | ILK | 0.97324045 |
| 41 | CSNK1G1 | 0.97188062 |
| 42 | WNK1 | 0.96009439 |
| 43 | CDK6 | 0.95426929 |
| 44 | RPS6KA5 | 0.95218695 |
| 45 | NTRK2 | 0.88652437 |
| 46 | TESK2 | 0.88045226 |
| 47 | SIK3 | 0.83028141 |
| 48 | CSNK1A1L | 0.81235536 |
| 49 | OXSR1 | 0.79839876 |
| 50 | MAP3K4 | 0.79387482 |
| 51 | PHKG1 | 0.73722549 |
| 52 | PHKG2 | 0.73722549 |
| 53 | WNK4 | 0.70709315 |
| 54 | CHEK2 | 0.68367581 |
| 55 | PIM2 | 0.67263278 |
| 56 | CDK12 | 0.65519659 |
| 57 | PKN1 | 0.65289596 |
| 58 | JAK3 | 0.61681787 |
| 59 | PIM1 | 0.60502389 |
| 60 | EIF2AK3 | 0.60261944 |
| 61 | EPHA4 | 0.59526015 |
| 62 | AURKA | 0.58548440 |
| 63 | BMPR1B | 0.56879367 |
| 64 | KDR | 0.55474564 |
| 65 | KSR1 | 0.54762592 |
| 66 | CSNK2A1 | 0.54067078 |
| 67 | CSF1R | 0.51986436 |
| 68 | HIPK2 | 0.51652106 |
| 69 | MINK1 | 0.50951552 |
| 70 | LMTK2 | 0.50872636 |
| 71 | DAPK3 | 0.49988411 |
| 72 | MYLK | 0.48383574 |
| 73 | FGFR2 | 0.48059575 |
| 74 | GRK1 | 0.42790595 |
| 75 | CSNK1A1 | 0.42527572 |
| 76 | NLK | 0.42185820 |
| 77 | PIK3CA | 0.41784605 |
| 78 | PRKCQ | 0.40785213 |
| 79 | GRK5 | 0.40339047 |
| 80 | CSNK1E | 0.40242174 |
| 81 | BUB1 | 0.40081527 |
| 82 | INSRR | 0.39771742 |
| 83 | FRK | 0.38479914 |
| 84 | PRKD3 | 0.38181649 |
| 85 | MAP3K9 | 0.33844209 |
| 86 | KIT | 0.33357838 |
| 87 | MAPK15 | 0.33300641 |
| 88 | DYRK3 | 0.33054939 |
| 89 | CSNK1D | 0.32675682 |
| 90 | PAK1 | 0.32566831 |
| 91 | GRK7 | 0.32406046 |
| 92 | JAK2 | 0.32379664 |
| 93 | CSNK2A2 | 0.32348738 |
| 94 | PRKACA | 0.31700911 |
| 95 | BLK | 0.31438487 |
| 96 | CDK5 | 0.31361538 |
| 97 | PRKCD | 0.30584550 |
| 98 | MST4 | 0.30442210 |
| 99 | AKT2 | 0.30227119 |
| 100 | MATK | 0.29658331 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.95629443 |
| 2 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.65408616 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.64580302 |
| 4 | Asthma_Homo sapiens_hsa05310 | 3.22281463 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 3.15328856 |
| 6 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.63876445 |
| 7 | Basal transcription factors_Homo sapiens_hsa03022 | 2.52591085 |
| 8 | Alzheimers disease_Homo sapiens_hsa05010 | 2.31681913 |
| 9 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.18750947 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.16665823 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.16053403 |
| 12 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.10815164 |
| 13 | Huntingtons disease_Homo sapiens_hsa05016 | 2.06785964 |
| 14 | Phototransduction_Homo sapiens_hsa04744 | 2.06561223 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.06058926 |
| 16 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.05713643 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.99248409 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.93938407 |
| 19 | RNA polymerase_Homo sapiens_hsa03020 | 1.81439321 |
| 20 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.78051125 |
| 21 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.68607837 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.62181380 |
| 23 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.60897630 |
| 24 | Protein export_Homo sapiens_hsa03060 | 1.59819645 |
| 25 | Proteasome_Homo sapiens_hsa03050 | 1.50169966 |
| 26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.49941289 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.40110441 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.36760129 |
| 29 | Alcoholism_Homo sapiens_hsa05034 | 1.29980826 |
| 30 | Nicotine addiction_Homo sapiens_hsa05033 | 1.28009427 |
| 31 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.23658890 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.19357728 |
| 33 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.15526078 |
| 34 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.08375427 |
| 35 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.02961126 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.02410663 |
| 37 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.01577366 |
| 38 | Olfactory transduction_Homo sapiens_hsa04740 | 0.92085729 |
| 39 | Circadian entrainment_Homo sapiens_hsa04713 | 0.90378375 |
| 40 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.82825774 |
| 41 | GABAergic synapse_Homo sapiens_hsa04727 | 0.82824819 |
| 42 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.79197536 |
| 43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.78180253 |
| 44 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.77778112 |
| 45 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.77708915 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.76562278 |
| 47 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.74320389 |
| 48 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.72613484 |
| 49 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.71720813 |
| 50 | Morphine addiction_Homo sapiens_hsa05032 | 0.71180344 |
| 51 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.71145703 |
| 52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.70403532 |
| 53 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.69904884 |
| 54 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.68646067 |
| 55 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68636845 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.67718198 |
| 57 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.66956050 |
| 58 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.66943963 |
| 59 | Spliceosome_Homo sapiens_hsa03040 | 0.66362235 |
| 60 | Salivary secretion_Homo sapiens_hsa04970 | 0.64948943 |
| 61 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.64200032 |
| 62 | Retinol metabolism_Homo sapiens_hsa00830 | 0.63379999 |
| 63 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.63095426 |
| 64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.61103115 |
| 65 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.60592150 |
| 66 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60169282 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58380070 |
| 68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56828675 |
| 69 | Leishmaniasis_Homo sapiens_hsa05140 | 0.56548706 |
| 70 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.54269192 |
| 71 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.50478473 |
| 72 | Phagosome_Homo sapiens_hsa04145 | 0.50461513 |
| 73 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.50351404 |
| 74 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.48797858 |
| 75 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46109656 |
| 76 | RNA degradation_Homo sapiens_hsa03018 | 0.45851061 |
| 77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.45310377 |
| 78 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.45128573 |
| 79 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.45034703 |
| 80 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.44095731 |
| 81 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.43000664 |
| 82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.42310951 |
| 83 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42181192 |
| 84 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40833437 |
| 85 | Cocaine addiction_Homo sapiens_hsa05030 | 0.40443801 |
| 86 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.39285768 |
| 87 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.37296688 |
| 88 | Apoptosis_Homo sapiens_hsa04210 | 0.37035036 |
| 89 | Axon guidance_Homo sapiens_hsa04360 | 0.36495230 |
| 90 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.35094197 |
| 91 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.34470106 |
| 92 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.33336233 |
| 93 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33063436 |
| 94 | Insulin secretion_Homo sapiens_hsa04911 | 0.32628275 |
| 95 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.31715109 |
| 96 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.30200253 |
| 97 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.27553519 |
| 98 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.27529527 |
| 99 | Tuberculosis_Homo sapiens_hsa05152 | 0.25311119 |
| 100 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.22918146 |

